Sugarloaf Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$64.9K Buy
703
+48
+7% +$4.32K 0.01% 274
2024
Q3
$54.9K Hold
655
0.01% 296
2024
Q2
$44.9K Hold
655
0.01% 303
2024
Q1
$48K Hold
655
0.01% 294
2023
Q4
$53.1K Sell
655
-926
-59% -$72.1K 0.01% 281
2023
Q3
$118K Buy
1,581
+9
+0.6% +$692 0.03% 190
2023
Q2
$121K Buy
1,572
+10
+0.6% +$798 0.03% 187
2023
Q1
$130K Sell
1,562
-23
-1% -$1.91K 0.03% 177
2022
Q4
$136K Buy
1,585
+31
+2% +$2.46K 0.03% 165
2022
Q3
$96K Sell
1,554
-113
-7% -$7.13K 0.02% 196
2022
Q2
$103K Buy
1,667
+11
+0.7% +$681 0.03% 182
2022
Q1
$98K Buy
1,656
+10
+0.6% +$639 0.02% 192
2021
Q4
$119K Sell
1,646
-215
-12% -$14.8K 0.03% 180
2021
Q3
$130K Sell
1,861
-60
-3% -$4.21K 0.03% 161
2021
Q2
$132K Buy
1,921
+144
+8% +$9.62K 0.04% 154
2021
Q1
$115 Sell
1,777
-397
-18% -$25.6K 0.03% 169
2020
Q4
$127K Sell
2,174
-174
-7% -$10.5K 0.04% 154
2020
Q3
$148K Buy
2,348
+3
+0.1% +$208 0.05% 128
2020
Q2
$180K Buy
2,345
+62
+3% +$4.75K 0.07% 117
2020
Q1
$171K Buy
2,283
+12
+0.5% +$829 0.08% 111
2019
Q4
$148K Buy
+2,271
New +$148K 0.06% 143

Other funds holding GILD

Sugarloaf Wealth Management's GILD Position: Q4 2024 in Review

Sugarloaf Wealth Management increased its Gilead Sciences (GILD) stake by 7.3% in Q4 2024, buying an estimated $4.32K and bringing the position to 703 shares worth $64.9K. The position accounts for 0.01% of the portfolio, ranked #274.

Sugarloaf Wealth Management first reported a position in GILD in Q4 2019 and has held it in 21 quarters since. The position peaked at $180K in Q2 2020. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Sugarloaf Wealth Management held 703 shares of Gilead Sciences worth $64.9K as of Q4 2024.
  • Sugarloaf Wealth Management bought 48 Gilead Sciences shares in Q4 2024, an estimated $4.32K.
  • Gilead Sciences made up 0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #274 holding.
  • Sugarloaf Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 21 quarters since.
  • Sugarloaf Wealth Management's Gilead Sciences position peaked at $180K in Q2 2020.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.